Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 86
Filter
1.
Contact Dermatitis ; 85(6): 686-692, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34293189

ABSTRACT

BACKGROUND: Occupational contact dermatitis often results in work disruption. Return-to-work (RTW) is an important outcome. OBJECTIVE: The objective of this study was to determine RTW outcomes and factors associated with such outcomes using a multidisciplinary clinic model. METHODS: Chart abstraction was performed for 194 workers who received RTW assistance over a 6-year period. Elements abstracted included demographic and diagnostic information and information about the RTW program including principles, program components, barriers, and facilitators. RESULTS: Of the 902 workers seen for dermatologic assessment, 194 received RTW assistance. At initial assessment, 37% were not working because of their skin disease, and at follow-up, 7% were not working because of their skin disease. The RTW plan components included a graduated or trial of RTW, specific recommendations for avoiding exposure, personal protective equipment, skin management, and ongoing skin monitoring. Principles associated with successful RTW included good communication and the availability of modified work and a worker adherence to the plan. Barriers included lack of modified work, unresponsive employers, and ongoing skin problems. CONCLUSIONS: Specific approaches are important to identify if RTW is to be successful for workers with occupational contact dermatitis.


Subject(s)
Dermatitis, Allergic Contact/therapy , Dermatitis, Irritant/therapy , Dermatitis, Occupational/therapy , Return to Work , Adult , Aged , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/prevention & control , Dermatitis, Irritant/diagnosis , Dermatitis, Irritant/prevention & control , Dermatitis, Occupational/diagnosis , Dermatitis, Occupational/prevention & control , Female , Humans , Male , Middle Aged , Patient Compliance , Patient Education as Topic , Personal Protective Equipment , Program Evaluation , Retrospective Studies , Skin Care , Young Adult
2.
Dermatitis ; 32(1): 63-67, 2021.
Article in English | MEDLINE | ID: mdl-31688132

ABSTRACT

BACKGROUND: There are no reported cases of 2,4-dichloro-5-methylpyrimidine (DCP)-induced irritant contact dermatitis (ICD). OBJECTIVE: The aim of the study was to summarize the clinical features, treatment, and protective measures for DCP-induced ICD. METHODS: We retrospectively reviewed the clinical data from 64 patients with DCP-induced ICD and the protective measures in a DCP manufacturing factory. RESULTS: Disease onset occurred 1 to 10 minutes after DCP single exposure in all 64 patients. The contact site developed edematous erythematous skin lesions with clear boundaries. Other symptoms included a burning sensation (n = 48), pruritus (n = 16), headache (n = 4), nausea/vomiting (n = 3), and syncope (n = 1). Ten patients developed pruritic rash over the whole body 1 to 4 days after contacting DCP. Histopathologic examination of the lesions was performed in 8 patients; all 8 showed manifestations of ICD. A patch test with 1% DCP ethanol solution was performed in 7 patients. One patient withdrew because of pruritus and massive erythema over the whole body. Four patients had a strong reaction, and 2 patients had a very strong reaction. All patients were cured. Positive-pressure inflatable protective clothing protected workers from the outside environment to prevent DCP-induced ICD. CONCLUSIONS: 2,4-Dichloro-5-methylpyrimidine exposure induces acute ICD and a delayed allergic reaction in some patients (15.6%). Positive-pressure inflatable protective clothing prevents DCP-induced ICD.


Subject(s)
Dermatitis, Irritant/physiopathology , Dermatitis, Occupational/physiopathology , Edema/physiopathology , Erythema/physiopathology , Pruritus/physiopathology , Acute Disease , Adult , Chemical Industry , Dermatitis, Irritant/etiology , Dermatitis, Irritant/prevention & control , Dermatitis, Irritant/therapy , Dermatitis, Occupational/etiology , Dermatitis, Occupational/prevention & control , Dermatitis, Occupational/therapy , Female , Headache/physiopathology , Humans , Male , Manufacturing and Industrial Facilities , Middle Aged , Nausea/physiopathology , Patch Tests , Protective Clothing , Pyrimidines/adverse effects , Vomiting/physiopathology
3.
Ann Acad Med Singap ; 49(9): 674-676, 2020 Sep.
Article in English | MEDLINE | ID: mdl-33241256

ABSTRACT

Coronavirus disease 2019 (COVID-19) pandemic continues to spread globally at a staggering speed. At present, there is no effective treatment or vaccine for COVID-19. Hand disinfection is a cost-effective way to prevent its transmission. According to the Centres for Disease Control and Prevention (CDC) guidelines, we should wash our hands with soap and water for at least 20 seconds. If soap and water are not readily available, alcohol-based hand rubs (ABHRs) with at least 60% alcohol are the alternative. With diligent hand disinfection reinforced during COVID-19, there is an increased prevalence of contact dermatitis. This commentary highlights the fact that contact dermatitis is a readily treatable condition and should not cause any deviation of proper hand hygiene. In irritant contact dermatitis (ICD), the management strategies are selection of less irritating hand hygiene products, frequent use of moisturisers to rebuild the skin barrier, and education on proper hand hygiene practices. In allergic contact dermatitis (ACD), the identification and avoidance of the contact allergen is the key to treatment. However, ACD is less common and only accounts for 20% of the cases. The identified allergens in hand cleansers are predominantly preservative excipients and ACD attributable to ABHR are very uncommon. Alcohol-free hand rubs are widely available on the market but it is not a recommended alternative to ABHRs by the CDC.


Subject(s)
COVID-19/prevention & control , Dermatitis, Allergic Contact/therapy , Dermatitis, Irritant/therapy , Emollients/therapeutic use , Hand Dermatoses/therapy , Hand Disinfection/methods , Hygroscopic Agents/therapeutic use , 1-Propanol/adverse effects , 2-Propanol/adverse effects , Anti-Infective Agents, Local/adverse effects , Dermatitis, Allergic Contact/etiology , Dermatitis, Irritant/etiology , Dermatitis, Occupational/etiology , Dermatitis, Occupational/therapy , Detergents/adverse effects , Ethanol/adverse effects , Hand Dermatoses/etiology , Hand Hygiene , Hand Sanitizers/adverse effects , Health Personnel , Humans
5.
Dermatol Clin ; 38(3): 329-338, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32475511

ABSTRACT

This article provides an overview of the evaluation and management of occupational contact dermatitis, including how to evaluate a patient with suspected occupational contact dermatitis. Patch testing, how to perform a site visit, and how to properly manage using preventative measures, prescribed therapies, and patient education are discussed.


Subject(s)
Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/therapy , Dermatitis, Occupational/diagnosis , Dermatitis, Occupational/therapy , Allergens/adverse effects , Dermatitis, Irritant/diagnosis , Dermatitis, Irritant/therapy , Disease Management , Evidence-Based Medicine , Female , Humans , Male , Patch Tests/statistics & numerical data
6.
Dermatol Clin ; 38(2): 227-232, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32115132

ABSTRACT

Evaluation of anogenital dermatitis requires a detailed history, including a sexual history. Men who have sex with men have different risk of certain infectious causes compared with men who have sex with women. Infectious causes of balanitis and anal dermatitis are easily treatable once identified. Irritant contact dermatitis is a common cause of balanitis, and avoidance of irritants, including decreased soap washing, helps many patients improve. Detailed histories of the personal products used by the patient and partner(s), including soaps, lotions, perfumes, lubricants, condoms, topical medications, hygiene sprays, personal wipes, and laundry detergent, may reveal possible irritants or contact allergens.


Subject(s)
Anus Diseases/therapy , Dermatitis, Allergic Contact/therapy , Dermatitis, Irritant/therapy , Genital Diseases, Male/therapy , Sexual and Gender Minorities , Sexually Transmitted Diseases/therapy , Anus Diseases/diagnosis , Condoms/adverse effects , Dermatitis/diagnosis , Dermatitis/therapy , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/etiology , Dermatitis, Irritant/diagnosis , Dermatitis, Irritant/etiology , Genital Diseases, Male/diagnosis , Humans , Lubricants/adverse effects , Lubricants/chemistry , Male , Sexually Transmitted Diseases/diagnosis , Soaps/adverse effects , Soaps/chemistry
7.
J Wound Care ; 29(1): 18-26, 2020 Jan 02.
Article in English | MEDLINE | ID: mdl-31930942

ABSTRACT

OBJECTIVE: Incontinence-associated dermatitis (IAD) is a common type of irritant contact dermatitis. It is categorised by persistent erythema and can be associated with denudation and/or colonisation and infection. IAD is challenging to treat and affects 3.4-50% of patients. This case series evaluates a novel, elastomeric, advanced skin protectant (3M Cavilon Advanced Skin Protectant) in a UK acute health-care setting, for the management of IAD in patients suffering from moisture-associated skin damage (MASD) in the sacral/genital area. METHOD: The patient's skin was assessed by clinicians using the GLOBIAD classification tool at the point of recruitment and to monitor progress throughout the study period. The product was applied as a single layer in accordance with the instructions for use. Patients, when able, were asked to assess their own pain level using the Wong-Baker FACES pain scale. Photographs were taken as part of the ongoing assessment. RESULTS: The skin protectant was used on average every 2.28 days. Of the 18 IAD patients recruited, 79% (n=11) were classified as IAD-free, based on the GLOBIAD categorisation tool, by the end of the evaluation period. Skin deterioration during the evaluation period was seen in one patient (6%), and of the patients able to complete pain assessments, 55% (n=6) reported a reduction in pain. CONCLUSION: These results suggest that the elastomeric skin protectant, applied every three days, plays a role in the improvement of IAD. The skin protectant adheres to wet and weeping partial-thickness wounds and may aid IAD management. Reducing application to every third day supports a change in practice which may offer benefits to patients and caregivers.


Subject(s)
Cyanoacrylates/administration & dosage , Dermatitis, Irritant/therapy , Elastomers/administration & dosage , Fecal Incontinence/complications , Protective Agents/administration & dosage , Urinary Incontinence/complications , Adult , Aged , Aged, 80 and over , Buttocks , Dermatitis, Irritant/etiology , Dermatitis, Irritant/prevention & control , Female , Humans , Male , Middle Aged , Skin/injuries , Skin Care/methods
9.
Contact Dermatitis ; 82(3): 153-160, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31794053

ABSTRACT

BACKGROUND: Irritant contact dermatitis is the most common type of hand eczema. Effective treatment usually involves avoidance of irritants and use of appropriate topical medication. In this study, the effectiveness of using text messaging addressing preventive behaviours and appropriate medication adherence was evaluated. METHODS: Patients who were admitted to Istanbul Training and Research Hospital Dermatology Department March 1, 2015 to July 31, 2015, and diagnosed with hand eczema were enrolled. Patients were randomly divided into the SMS group and the non-SMS group. Text messages were sent to the mobile phones of the patients in the SMS group. Severity of hand eczema, compliance to treatment, patients' information level, adherence to preventive behaviours, and the protective behaviour score were evaluated at baseline, and at the 4th and 8th week. RESULTS: Eighty-one patients with hand eczema were included in the study. After 8 weeks, the decrease in the Hand Eczema Severity Index score was 70.2% (SD 35.2) in the SMS group and 38.9% (SD 67.7) in the non-SMS group (P = .017). Sending SMS to patients increased the use of moisturizer. There was no statistically significant difference in other behaviours. CONCLUSION: This study demonstrated that text messaging improves the treatment success and specifically the frequency of moisturizer use in patients with hand eczema.


Subject(s)
Behavior Therapy , Dermatitis, Allergic Contact/therapy , Dermatitis, Irritant/therapy , Medication Adherence , Text Messaging , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Emollients/therapeutic use , Gloves, Protective , Hand Disinfection/methods , Health Knowledge, Attitudes, Practice , Humans , Middle Aged , Severity of Illness Index , Skin Cream/therapeutic use , Treatment Outcome , Visual Analog Scale , Young Adult
10.
Drugs Aging ; 36(5): 411-417, 2019 05.
Article in English | MEDLINE | ID: mdl-31037642

ABSTRACT

Increased aging of the general population is a well-known fact with serious effects on health systems worldwide. Skin aging involves various immunological and structural changes that increase the risk of numerous skin diseases such as contact dermatitis. Contact dermatitis is characterized by an inflammation of the skin caused by an interaction between the skin and external agents and is divided into irritant and allergic contact dermatitis. Irritant contact dermatitis occurs on skin areas directly exposed to irritant substances, which results in a stream of pro-inflammatory cytokines mediating the skin injury. Asteatotic and perineal irritant contact dermatitis are the most important subtypes of irritant contact dermatitis in the elderly. Allergic contact dermatitis is a T cell-mediated inflammatory reaction and requires a prior sensitization. The most common allergens responsible for allergic contact dermatitis in the elderly are fragrance mix, nickel, and balsam of Peru. Elderly patients with stasis dermatitis, chronic wounds, and chronic venous insufficiency have an increased prevalence of sensitization due to the frequent exposure to topical treatments. In this review, the most common types of contact dermatitis in the elderly are enumerated in order to assist dermatologists and other physicians to identify contact dermatitis in this distinct group of the population.


Subject(s)
Aging/drug effects , Allergens/toxicity , Dermatitis, Allergic Contact/etiology , Dermatitis, Irritant/etiology , Skin/drug effects , Aged , Aging/radiation effects , Dermatitis, Allergic Contact/immunology , Dermatitis, Allergic Contact/therapy , Dermatitis, Irritant/immunology , Dermatitis, Irritant/therapy , Disease Management , Female , Humans , Male , Prevalence , Risk Factors , Skin/radiation effects
11.
Skinmed ; 17(1): 30-34, 2019.
Article in English | MEDLINE | ID: mdl-30888945

ABSTRACT

Hand dermatitis is a common skin disorder that can negatively impact a patient's daily life and occupation. The necessity and frequency of hand use can expose the overlying skin to irritation, trauma, and observation from others. This can make hand dermatitis irritating to active hands and difficult to treat, as irritant exposure is often difficult to avoid. Due to the variable degrees of presentations of hand dermatitis, it is essential for dermatologists to adequately recognize the variable presentation, establish a definitive diagnosis, and develop an appropriate treatment. This review explores the pathogenesis, clinical types, diagnosis methods, treatment, and prognosis of hand dermatitis. (SKINmed. 2019;17:30-34).


Subject(s)
Dermatitis, Irritant/pathology , Hand Dermatoses/pathology , Irritants/adverse effects , Dermatitis, Irritant/diagnosis , Dermatitis, Irritant/therapy , Hand Dermatoses/diagnosis , Hand Dermatoses/therapy , Humans , Prognosis , Skin/pathology
12.
Clin Rev Allergy Immunol ; 56(1): 1-8, 2019 Feb.
Article in English | MEDLINE | ID: mdl-29754191

ABSTRACT

Irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD) are common skin disorders that are characterized by inflammation, oozing, crusting, and pruritus. Atopic dermatitis (AD) is an inflammatory skin disease characterized by immune and barrier abnormalities and is additionally a risk factor for acquiring ICD and ACD. New work on allergic sensitization to common allergens (e.g., nickel and fragrance) in human skin has shown that different allergens have distinct molecular fingerprinting. For example, nickel promotes strong Th1/Th17 polarization, whereas fragrance allergy causes Th2/Th22 skewing, which is similar to the phenotype of AD. While ACD has previously been considered to be constant across all allergens, largely based on mouse models involving strong sensitizers, these new data suggest that ACD differs mechanistically according to allergen. Further, ACD in the setting of concurrent AD shows a different and attenuated phenotype as compared to healthy individuals with ACD, which influences the way AD patients respond to vaccination and other treatment modalities. As in contact sensitization, skin challenged by food patch testing shows that common food allergens (e.g., peanut and barley) also cause distinct immune polarizations in the skin. Additionally, house dust mite reactions in human skin have been profiled to show unique Th2, Th9, and Th17/22 activation as compared to controls, which are similar to the phenotype of psoriasis and contact responses to nickel. Given this information, ACD patients should be treated based on their unique allergen polarity. Refined understanding of the molecular behavior of contact dermatitis and related diseases translates to improved methods of inducing tolerance in sensitized allergic patients, such as with targeted drug therapy and epicutaneous immunotherapy.


Subject(s)
Allergens/immunology , Dermatitis, Atopic/etiology , Dermatitis, Atopic/metabolism , Lymphocyte Activation/immunology , T-Lymphocyte Subsets/immunology , Animals , Biomarkers , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Allergic Contact/etiology , Dermatitis, Allergic Contact/metabolism , Dermatitis, Allergic Contact/therapy , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/therapy , Dermatitis, Irritant/diagnosis , Dermatitis, Irritant/etiology , Dermatitis, Irritant/metabolism , Dermatitis, Irritant/therapy , Humans , Skin Tests , T-Lymphocyte Subsets/metabolism
13.
Ultrasonics ; 91: 206-212, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30122437

ABSTRACT

BACKGROUND: Surfactant-induced skin barrier disruption can enhance blood flow and water content in the superficial skin. The effect of therapeutic ultrasound on accelerating the recovery of superficial skin after skin barrier disruption has seldom been studied. OBJECTIVE: To understand the effects of therapeutic ultrasound on barrier recovery, we used the sodium lauryl sulfate irritation model and treatment with ultrasound intervention. METHODS: The study allocated 30 healthy subjects into an ultrasound group (n = 15) and a control group (n = 15), each divided into three subgroups (sodium lauryl sulfate at concentrations of 1.0%, 0.5%, and 0%). Pulsed ultrasound (1 MHz, 0.3 W/cm2SATA) was applied to ultrasound subgroups. The treatment effect was evaluated by the recovery rate of enhanced blood flow and water content. RESULTS: The results indicated a surfactant dose-dependent effect on blood flow, but not on water content. The recovery rates of enhanced blood flow were higher in the 0.5% and 1.0% ultrasound subgroups than in the control subgroups throughout the experiment. However, recovery rates of water content were higher in the ultrasound subgroups than in the control subgroups only on Day2. CONCLUSIONS: Pulsed ultrasound accelerated the barrier recovery by reducing the enhanced blood flow and water content after skin barrier disruption.


Subject(s)
Dermatitis, Irritant/therapy , Sodium Dodecyl Sulfate/adverse effects , Surface-Active Agents/adverse effects , Ultrasonic Therapy , Adult , Dermatitis, Irritant/etiology , Female , Humans , Male , Skin/blood supply , Skin/drug effects , Skin Irritancy Tests , Skin Physiological Phenomena , Young Adult
14.
Am J Trop Med Hyg ; 98(5): 1523-1525, 2018 05.
Article in English | MEDLINE | ID: mdl-29611499

ABSTRACT

Rash in the returned traveler can provide a diagnostic dilemma for clinicians, but a detailed history including epidemiologic exposures can allow prompt diagnosis of etiologies uncommon in the United States. One such disease is Paederus dermatitis, an irritant contact dermatitis related to exposure to the rove beetle characterized by bullous lesions with surrounding erythema. Although cases and outbreaks have commonly been reported throughout the world, they are rarely reported in travelers returning to the United States. Here, we describe a patient who presented to an academic medical center in Virginia after travel to Sierra Leone with clinical presentation including exposure history and histopathology consistent with Paederus dermatitis. Our patient's clinic course is described in detail including treatment. Usual treatment includes antihistamines, topical steroids, and oral antibiotics, particularly with antimicrobials with activity against Pseudomonas sp. In addition, this case suggests a potential role for oral steroids in the treatment of this condition but further investigation is required. This case demonstrates the importance of considering a patient's travel and exposure history, as well as having familiarity with disease processes common in other parts of the world that are rarely seen in the United States.


Subject(s)
Coleoptera , Dermatitis, Irritant/etiology , Dermatitis, Irritant/pathology , Animals , Cellulitis/drug therapy , Cellulitis/etiology , Dermatitis, Irritant/therapy , Doxycycline/administration & dosage , Doxycycline/therapeutic use , Female , Histamine Antagonists/therapeutic use , Humans , Levofloxacin/administration & dosage , Levofloxacin/therapeutic use , Liberia , Middle Aged , Sierra Leone , Travel , Virginia
15.
Ann Allergy Asthma Immunol ; 120(6): 592-598, 2018 06.
Article in English | MEDLINE | ID: mdl-29522811

ABSTRACT

OBJECTIVE: To review of contact dermatitis (CD) and its key allergens and provide updates and recommendations for the practicing allergist. DATA SOURCES: Through the use of various scientific search engines (eg, PubMed and MEDLINE), we reviewed literature on CD, patch tests (PTs), key allergens, occupational dermatitis, and treatment. STUDY SELECTIONS: Studies on CD, important allergens, and PTs were considered. RESULTS: Contact-induced dermatitis may be due to allergic CD, irritant CD, systemic CD, contact urticaria, and protein CD. Key allergens include metals (nickel, gold), topical medicaments (topical corticosteroids), and cosmetics and personal care products (fragrances and preservatives such as methyl- and methylchloro-isothiazolinone). Present relevance of a positive PT result is the combination of definite, probable, and possible relevance and should be correlated with the patient's history and physical examination. Treatment of allergic CD includes identification of relevant allergens, patient education, avoidance, and provision of alternative products the patient can use. CONCLUSION: CD is a common inflammatory skin disease and should be suspected in patients presenting with acute, subacute, or chronic dermatitis. The gold standard for diagnosing allergic CD is a PT. This article provides practical recommendations for the diagnosis and management of CD commonly seen by the allergist in their practice.


Subject(s)
Allergens/adverse effects , Dermatitis, Allergic Contact/diagnosis , Dermatitis, Irritant/diagnosis , Erythema/diagnosis , Pruritus/diagnosis , Adrenal Cortex Hormones/therapeutic use , Avoidance Learning , Balsams/adverse effects , Cosmetics/adverse effects , Dermatitis, Allergic Contact/etiology , Dermatitis, Allergic Contact/immunology , Dermatitis, Allergic Contact/therapy , Dermatitis, Irritant/etiology , Dermatitis, Irritant/immunology , Dermatitis, Irritant/therapy , Diagnosis, Differential , Erythema/etiology , Erythema/immunology , Erythema/therapy , Humans , Nickel/adverse effects , Odorants/analysis , Patch Tests , Pruritus/etiology , Pruritus/immunology , Pruritus/therapy , Skin/drug effects , Skin/immunology , Skin/pathology
16.
Ann Plast Surg ; 80(2S Suppl 1): S26-S29, 2018 02.
Article in English | MEDLINE | ID: mdl-29369914

ABSTRACT

Nd:YAG laser has been used extensively for its versatility in treating many common aesthetic problems, but numerous adverse effects are often complained by recipients of Nd:YAG laser. This study introduces the ANT1 soybean extract cream, which was formulated to alleviate adverse effects after laser therapy. This study explores whether ANT1 enhances the repair mechanism of the postlaser skin, decreases laser-induced complication, and shortens recovery time. The study also aims to pinpoint the ANT1 concentration that is most effective in improving the skin condition after Nd-YAG laser therapy. MATERIALS AND METHODS: This study was a single-center, randomized, double-blind, placebo-controlled trial. Patients eligible for the study were Asian women, aged 25 to 40 years, who were free of dermatological diseases and allergic reaction. There were a total of 45 subjects. Each subject received a session of Nd-YAG laser therapy every 2 weeks, totaling 3 sessions. Facial skin assessment was achieved via VISIA complexion analysis. VISIA complexion analysis quantitatively assessed the skin condition and tracked the recovery progress of each subject at baseline, immediately after all 3 laser sessions, and a week after the final laser treatment. RESULTS: Skin condition was evaluated by VISIA complexion analysis. Skin condition was recorded in aspects of pigmented spots, wrinkles, texture, pores, and red area. After Nd-YAG laser therapy, postlaser inflammation was observed in all subjects. Throughout the laser sessions and the outpatient follow-up clinic, the adverse effects of laser therapy, such as redness, spots, wrinkles, pores, and textures, decreased with the use of ANT1 cream. There has been a marked effect in wrinkle reduction in the patients who received a higher concentration of ANT1 cream (P ≤ 0.05). Statistically significant improvement in spots and pores is also seen (P ≤ 0.05). CONCLUSIONS: Through this study, the results suggest that the application of ANT1 soybean extract cream ameliorates the complications and enhances the cosmetic effects of Nd-YAG laser therapy. A higher concentration of the ANT1 cream significantly reduces wrinkles and redness after laser. All in all, this study proves that the ANT1 soy extract cream may be a useful addition to postlaser care for an overall enhancement in skin condition and recovery.


Subject(s)
Dermatitis, Irritant/etiology , Dermatitis, Irritant/therapy , Glycine max , Lasers, Solid-State/therapeutic use , Low-Level Light Therapy/adverse effects , Plant Extracts/therapeutic use , Academic Medical Centers , Administration, Topical , Adult , Double-Blind Method , Emollients , Esthetics , Female , Follow-Up Studies , Humans , Lasers, Solid-State/adverse effects , Low-Level Light Therapy/methods , Reference Values , Risk Assessment , Taiwan , Treatment Outcome , Young Adult
17.
Drugs Aging ; 35(1): 1-10, 2018 01.
Article in English | MEDLINE | ID: mdl-29243033

ABSTRACT

Incontinence-associated dermatitis (IAD) is a common type of irritant contact dermatitis, seen in patients with urinary or faecal incontinence. Mechanical factors such as traumata and friction may aggravate the lesions. The fragile skin in elderly patients is more prone to developing IAD. The clinical picture of IAD consists of persistent redness on the one hand and skin loss on the other. Both categories may be associated with clinical signs of major colonisation or infection. It is important to distinguish IAD from pressure ulcers and other dermatoses in the genital region. Due to the lack of well-established clinical trials, recommendations about prevention and treatment are based on expert opinion and best practice. Gentle cleansing, use of hydrating topical agents and application of barrier products are the main elements in the prevention and treatment of IAD. It is important to translate these recommendations and general guidelines into ready-to-use protocols that can be implemented for each specific clinical manifestation of IAD.


Subject(s)
Dermatitis, Irritant/etiology , Dermatitis, Irritant/therapy , Fecal Incontinence/complications , Skin Care/methods , Urinary Incontinence/complications , Aged , Dermatitis, Irritant/prevention & control , Fecal Incontinence/therapy , Humans , Urinary Incontinence/therapy
18.
Adv Skin Wound Care ; 30(11): 494-501, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29049257

ABSTRACT

BACKGROUND: Protecting the skin against moisture-associated damage is an important component of comprehensive skin and wound care. Based on a review of literature, the authors propose key interventions to protect and prevent damage in the skin folds, perineum, and areas surrounding a wound or stoma. OBJECTIVE: The aim of this scoping review is to identify and provide a narrative integration of the existing evidence related to the management and prevention of moisture-associated skin damage (MASD). METHODS: Study authors searched several databases for a broad spectrum of published and unpublished studies in English, published between 2000 and July 2015. Selected study information was collated in several different formats; ultimately, key findings were aggregated into a thematic description of the evidence to help generate a set of summative statements or recommendations. RESULTS: Based on inclusion criteria, 37 articles were considered appropriate for this review. Findings included functional definitions and prevalence rates of the 4 types of MASD, assessment scales for each, and 7 evidence-based strategies for the management of MASD. CONCLUSIONS: Based on this scoping review of literature, the authors propose key interventions to protect and prevent MASD including the use of barrier ointments, liquid polymers, and cyanoacrylates to create a protective layer that simultaneously maintains hydration levels while blocking external moisture and irritants.


Subject(s)
Body Fluids , Dermatitis, Irritant/etiology , Dermatitis, Irritant/therapy , Fecal Incontinence/complications , Skin Care/methods , Surgical Stomas/adverse effects , Urinary Incontinence/complications , Dermatitis, Irritant/physiopathology , Female , Humans , Male , Risk Assessment , Treatment Outcome
19.
Indian J Dermatol Venereol Leprol ; 83(4): 424-431, 2017.
Article in English | MEDLINE | ID: mdl-28584222

ABSTRACT

Paederus dermatitis is an irritant dermatitis caused by pederin, a toxin produced by the rove beetle (Paederus). The disease occurs worldwide, but it is often not recognized as a history of contact with the insect is frequently absent. It is commonly seen in the rainy season. Crushing the insect releases pederin, resulting in the characteristic linear lesions with a burning sensation that heal with hyperpigmentation. Treatment comprises immediate washing of the area to eliminate the toxin and topical application of a topical steroid-antibiotic combination. Preventive measures may include reducing the insect population in the surroundings, avoiding contact of insects with the skin, minimizing the lesions after contact. Awareness of the etiology and clinical manifestations makes it easier to suspect this condition even in the absence of a history of exposure to the insect. We present a comprehensive review of the etiopathogenesis, pathology, clinical features, treatment and prevention of Paederus dermatitis and also review the biology of the insect and its behavior.


Subject(s)
Dermatitis, Irritant/etiology , Dermatitis, Irritant/pathology , Pyrans/toxicity , Toxins, Biological/toxicity , Animals , Coleoptera , Dermatitis, Irritant/therapy , Humans
20.
J Tissue Viability ; 26(1): 47-56, 2017 Feb.
Article in English | MEDLINE | ID: mdl-26949126

ABSTRACT

BACKGROUND: Incontinence-Associated Dermatitis (IAD) is one of the clinical manifestations of Moisture- Associated Skin Damage (MASD). IAD is a common problem in aged patients with fecal and/or urinary incontinence. AIM: Update about IAD terminology, etiology, epidemiology, observation, prevention, and treatment. METHODS: Integrative review. RESULTS: The lack of an ICD-10 code and an internationally validated and standardized method for IAD data collection contribute to a variation in epidemiological data. Frequent episodes of incontinence (especially fecal), occlusive containment products, poor skin condition, reduced mobility, diminished cognitive awareness, inability to perform personal hygiene, pain, pyrexia, certain medications (antibiotics, immunosuppressants), poor nutritional status, and critical illness are associated with IAD. Correctly diagnosing IAD and distinguish it from pressure ulcers is difficult. Even though the clinical presentation of partial thickness pressure ulcers and IAD is similar, the underlying etiologic factors differ. However, incontinence and IAD were found to be risk factors for pressure ulcer development. IAD management should essentially focus on skin cleansing to remove dirt, debris and microorganisms; skin moisturization to repair or augment the skin's barrier; and the application of a skin barrier product to prevent skin breakdown by providing an impermeable or semi-permeable barrier on the skin. The body of evidence is still limited, but growing since the last decade. CONCLUSION: Incontinence causes disruptions of the skin barrier function and leads to superficial skin damage. Macerated skin and superficial skin changes due to incontinence are associated with pressure ulcer development. Skin maceration, chemical irritation, and physical irritation should be targeted to effectively prevent and treat IAD.


Subject(s)
Dermatitis, Irritant , Fecal Incontinence/complications , Pressure Ulcer/etiology , Urinary Incontinence/complications , Aged , Dermatitis, Irritant/diagnosis , Dermatitis, Irritant/etiology , Dermatitis, Irritant/prevention & control , Dermatitis, Irritant/therapy , Dermatologic Agents/administration & dosage , Dermatologic Agents/pharmacology , Humans , Pressure Ulcer/prevention & control , Risk Factors , Skin/chemistry , Skin Care
SELECTION OF CITATIONS
SEARCH DETAIL
...